Informações:
Falhas:
ID
32706
Descrição
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Palavras-chave
Versões (1)
- 13.11.18 13.11.18 -
Titular dos direitos
GSK group of companies
Transferido a
13. November 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Estimation of Dose Proportionality of Darapladib - 107038
Logs and Repeats: General Adverse Event and Concomitant Medication Questions
Similar models
Logs and Repeats: General Adverse Event and Concomitant Medication Questions
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Date below is the start of the study for this subject
Item
Date below is the start of the study for this subject
date
Item Group
Adverse Event/Concomitant Medications/Repeat Assessment (Check Questions)
Were any concomitant medications taken by the subject during the study?
Item
Were any concomitant medications taken by the subject during the study?
boolean
Did the subject experience any adverse events during the study?
Item
Did the subject experience any adverse events during the study?
boolean
Were any repeat ECGs performed?
Item
Were any repeat ECGs performed?
boolean
Were any repeat/unscheduled PK samples taken?
Item
Were any repeat/unscheduled PK samples taken?
boolean
Were any repeat/unscheduled PD samples taken?
Item
Were any repeat/unscheduled PD samples taken?
boolean